BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

355 related articles for article (PubMed ID: 16799960)

  • 1. TIP30 inhibits growth of HCC cell lines and inhibits HCC xenografts in mice in combination with 5-FU.
    Zhao J; Zhang X; Shi M; Xu H; Jin J; Ni H; Yang S; Dai J; Wu M; Guo Y
    Hepatology; 2006 Jul; 44(1):205-15. PubMed ID: 16799960
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of tumor suppressing gene TIP30/CC3 on the growth of tumor cells].
    Zhang X; Ouyang XN; Li XD; Zhao J; Guo YJ
    Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):38-41. PubMed ID: 15670490
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TIP30 mutant derived from hepatocellular carcinoma specimens promotes growth of HepG2 cells through up-regulation of N-cadherin.
    Jiang C; Pecha J; Hoshino I; Ankrapp D; Xiao H
    Cancer Res; 2007 Apr; 67(8):3574-82. PubMed ID: 17440068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Construction of adenovirus vector expressing TIP30 and its tumor suppressive effect in vitro and in vivo].
    Zhang X; Zhao J; Li XD; Yuan CT; Wang HQ; Wu MC; Xiao H; Guo YJ
    Zhonghua Zhong Liu Za Zhi; 2004 Feb; 26(2):85-8. PubMed ID: 15059324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thirty-kilodalton Tat-interacting protein suppresses tumor metastasis by inhibition of osteopontin transcription in human hepatocellular carcinoma.
    Zhao J; Lu B; Xu H; Tong X; Wu G; Zhang X; Liang A; Cong W; Dai J; Wang H; Wu M; Guo Y
    Hepatology; 2008 Jul; 48(1):265-75. PubMed ID: 18537194
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation of Tip30 promoter is associated with poor prognosis in human hepatocellular carcinoma.
    Lu B; Ma Y; Wu G; Tong X; Guo H; Liang A; Cong W; Liu C; Wang H; Wu M; Zhao J; Guo Y
    Clin Cancer Res; 2008 Nov; 14(22):7405-12. PubMed ID: 19010857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiproliferative effects of 5-fluorouracil and interferon-alpha in combination on a hepatocellular carcinoma cell line in vitro and in vivo.
    Kojiro S; Yano H; Ogasawara S; Momosaki S; Takemoto Y; Nishida N; Kojiro M
    J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):129-37. PubMed ID: 16706824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TIP30 deficiency increases susceptibility to tumorigenesis.
    Ito M; Jiang C; Krumm K; Zhang X; Pecha J; Zhao J; Guo Y; Roeder RG; Xiao H
    Cancer Res; 2003 Dec; 63(24):8763-7. PubMed ID: 14695192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TIP30/CC3 expression in breast carcinoma: relation to metastasis, clinicopathologic parameters, and P53 expression.
    Zhao J; Ni H; Ma Y; Dong L; Dai J; Zhao F; Yan X; Lu B; Xu H; Guo Y
    Hum Pathol; 2007 Feb; 38(2):293-8. PubMed ID: 17097132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of growth and metastasis of human hepatocellular carcinoma by antisense oligonucleotide targeting signal transducer and activator of transcription 3.
    Li WC; Ye SL; Sun RX; Liu YK; Tang ZY; Kim Y; Karras JG; Zhang H
    Clin Cancer Res; 2006 Dec; 12(23):7140-8. PubMed ID: 17145839
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of osteopontin suppresses growth and metastasis of hepatocellular carcinoma via induction of apoptosis.
    Zhao J; Dong L; Lu B; Wu G; Xu D; Chen J; Li K; Tong X; Dai J; Yao S; Wu M; Guo Y
    Gastroenterology; 2008 Sep; 135(3):956-68. PubMed ID: 18555021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RASSF1A expression inhibits the growth of hepatocellular carcinoma from Qidong County.
    Xue WJ; Li C; Zhou XJ; Guan HG; Qin L; Li P; Wang ZW; Qian HX
    J Gastroenterol Hepatol; 2008 Sep; 23(9):1448-58. PubMed ID: 17683489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TIP30 induces apoptosis under oxidative stress through stabilization of p53 messenger RNA in human hepatocellular carcinoma.
    Zhao J; Chen J; Lu B; Dong L; Wang H; Bi C; Wu G; Guo H; Wu M; Guo Y
    Cancer Res; 2008 Jun; 68(11):4133-41. PubMed ID: 18519672
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of the Fas/FasL pathway in combination therapy with interferon-alpha and fluorouracil against hepatocellular carcinoma in vitro.
    Nakamura M; Nagano H; Sakon M; Yamamoto T; Ota H; Wada H; Damdinsuren B; Noda T; Marubashi S; Miyamoto A; Takeda Y; Umeshita K; Nakamori S; Dono K; Monden M
    J Hepatol; 2007 Jan; 46(1):77-88. PubMed ID: 17045692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transfection of Smac sensitizes tumor cells to etoposide-induced apoptosis and eradicates established human hepatoma in vivo.
    Zhao J; Jin J; Zhang X; Shi M; Dai J; Wu M; Wang R; Guo Y
    Cancer Gene Ther; 2006 Apr; 13(4):420-7. PubMed ID: 16211087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bid sensitizes apoptosis induced by chemotherapeutic drugs in hepatocellular carcinoma.
    Miao J; Chen GG; Chun SY; Chak EC; Lai PB
    Int J Oncol; 2004 Sep; 25(3):651-9. PubMed ID: 15289866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survivin knockdown by short hairpin RNA abrogates the growth of human hepatocellular carcinoma xenografts in nude mice.
    Zhang R; Ma L; Zheng M; Ren J; Wang T; Meng Y; Zhao J; Jia L; Yao L; Han H; Li K; Yang A
    Cancer Gene Ther; 2010 Apr; 17(4):275-88. PubMed ID: 19876077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synergistic inhibition of hepatocellular carcinoma growth and hepatocarcinogenesis by combination of 5-fluorouracil and angiotensin-converting enzyme inhibitor via anti-angiogenic activities.
    Yanase K; Yoshiji H; Ikenaka Y; Noguchi R; Kitade M; Kaji K; Yoshii J; Namisaki T; Yamazaki M; Asada K; Tsujimoto T; Akahane T; Uemura M; Fukui H
    Oncol Rep; 2007 Feb; 17(2):441-6. PubMed ID: 17203185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The monoclonal antibody CH12 augments 5-fluorouracil-induced growth suppression of hepatocellular carcinoma xenografts expressing epidermal growth factor receptor variant III.
    Jiang H; Dong Q; Luo X; Shi B; Wang H; Gao H; Kong J; Zhang J; Li Z
    Cancer Lett; 2014 Jan; 342(1):113-20. PubMed ID: 24007863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor receptor vIII enhances tumorigenicity and resistance to 5-fluorouracil in human hepatocellular carcinoma.
    Wang H; Jiang H; Zhou M; Xu Z; Liu S; Shi B; Yao X; Yao M; Gu J; Li Z
    Cancer Lett; 2009 Jun; 279(1):30-8. PubMed ID: 19217205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.